Lazard Asset Management’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Lazard Asset Management's CLBT Position: Q2 2026 in Review
Lazard Asset Management increased its Cellebrite (CLBT) stake by 2.5% in Q2 2026, buying an estimated $51.4K and bringing the position to 158,751 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #918.
Lazard Asset Management first reported a position in CLBT in Q4 2022 and has held it in 14 quarters since. The position peaked at $9.42M in Q3 2025. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Lazard Asset Management held 158,751 shares of Cellebrite worth $2.32M as of Q2 2026.
- Lazard Asset Management bought 3,888 Cellebrite shares in Q2 2026, an estimated $51.4K.
- Cellebrite made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #918 holding.
- Lazard Asset Management first reported a position in Cellebrite in Q4 2022 and has held it in 14 quarters since.
- Lazard Asset Management's Cellebrite position peaked at $9.42M in Q3 2025.
- 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.